Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The clinical trial is a double-blind, randomized, placebo-controlled study to assess the efficacy and safety of administering semaglutide 2.4 mg in 150 obese Asian patients weekly
Although semaglutide has many benefits, there are some risks to be aware of
Results should be interpreted by a qualified healthcare provider as one data point within a broader clinical evaluation
And a path to bariatric surgery if appropriate, he said, adding that the program delivers 19% sustained weight loss at 36 months
:max_bytes(150000):strip_icc()/Health-GettyImages-1675158771-70640c9fdf1b41078975cfc3fd538a6b.jpg)
US$ 25.39
US$ 22.52
US$ 20.78
US$ 20.75
US$ 21.45
